NCT04664933

Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET)

Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET): One Single Center, Safety and Feasibility Study

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Hui-Sheng Chen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To explore the safety and feasibility of intra-arterial neuroprotective strategy in acute ischemic stroke patients who received recanalization operation.

Conditions

• Stroke, Ischemic
• Intravascular Thrombosis
• Mechanical Thrombectomy

Interventions

Type	Name	Description
DRUG	Intra-arterial administration of neuroprotective agents	Intra-arterial administration of 3-n-butylphthalide for 16 to 24 hours during and after the operation at 17.36 to 26.04 ug/min

Timeline

• Start date: 2020-12-01
• Primary completion: 2026-05-31
• Completion: 2026-05-31
• First posted: 2020-12-11
• Last updated: 2025-08-21

Locations

1 site across 1 country: China